| Price | 15.50p on 05-03-2026 at 07:53:42 |
|---|---|
| Change | 0.00p 0% |
| Buy | 16.00p |
| Sell | 15.00p |
| Last Trade: | Sell 13,500.00 at 15.30p |
| Day's Volume: | 0 |
| Last Close: | 15.50p |
| Open: | 0.00p |
| ISIN: | GB00BMC3RJ87 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 9.00p - 28.00p |
| Market Capitalisation: | £21.40m |
| VWAP: | 0.00p |
| Shares in Issue: | 138.07m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Sareum (SAR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 13,500 | 15.30p | Ordinary |
16:27:13 - 04-Mar-26 |
| Buy* | 19,108 | 15.70p | Ordinary |
14:51:42 - 04-Mar-26 |
| Buy* | 2,000 | 15.75p | Ordinary |
13:13:20 - 04-Mar-26 |
| Sell* | 75,000 | 15.26p | Ordinary |
10:47:11 - 04-Mar-26 |
| Sell* | 13,141 | 15.25p | Ordinary |
10:01:31 - 04-Mar-26 |
| Buy* | 31,421 | 15.90p | Ordinary |
15:59:08 - 03-Mar-26 |
| Sell* | 6,000 | 15.20p | Ordinary |
14:41:27 - 03-Mar-26 |
| Buy* | 6,229 | 15.90p | Ordinary |
13:52:39 - 03-Mar-26 |
| Buy* | 31,470 | 15.875p | Ordinary |
12:05:27 - 03-Mar-26 |
| Buy* | 13,000 | 15.90p | Ordinary |
11:25:57 - 03-Mar-26 |
Sareum (SAR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Mar 2026 7:00 am | RNS | Notice of Results and Investor Presentation |
| 17th Feb 2026 7:00 am | RNS | Restart of Phase 2-enabling toxicology programme |
| 23rd Jan 2026 4:36 pm | RNS | Form 8.3 - Oxford Biomedica plc |
| 9th Dec 2025 4:25 pm | RNS | Results of AGM |
| 9th Dec 2025 7:00 am | RNS | Annual General Meeting Statement |
| 17th Nov 2025 7:00 am | RNS | Notice of AGM, Annual Report and Accounts |
| 30th Oct 2025 7:00 am | RNS | Appointment of Joint Corporate Broker |
| 23rd Oct 2025 7:00 am | RNS | Preliminary Results for Year Ended 30 June 2025 |
| 10th Oct 2025 7:00 am | RNS | Update on toxicology study for SDC-1801 |
| 7th Oct 2025 7:00 am | RNS | Notice of Results and Investor Presentation |
